Table 3.
Relationship between clinicopathological variables and FEN1 expression level in TCGA database.
| Characteristics | FEN1 | |||
|---|---|---|---|---|
| Low | High | P value | ||
| Gender | Male | 123 (54.9%) | 101 (45.1%) | 0.006 |
| Female | 40 (38.5%) | 64 (61.5%) | ||
|
| ||||
| Age | <Median | 76 (47.2%) | 85 (52.8%) | 0.376 |
| ≥Median | 87 (52.1%) | 80 (47.9%) | ||
|
| ||||
| Race | White | 90 (56.6%) | 69 (43.4%) | 0.015 |
| Others | 73 (43.2%) | 96 (56.8%) | ||
|
| ||||
| TNM stage | Stage I/II | 136 (55.5%) | 109 (44.5%) | <0.001 |
| Stage III/IV | 27 (32.5%) | 56 (67.5%) | ||
|
| ||||
| Histologic grade | Grade I/II | 117 (58.2%) | 84 (41.8%) | <0.001 |
| Grade III/IV | 46 (36.2%) | 81 (63.8%) | ||
|
| ||||
| AFP | Low | 99 (63.1%) | 58 (36.9%) | <0.001 |
| High | 64 (37.4%) | 107 (62.6%) | ||